Moderate physical exercise does not cause any changes in the plasma levels of the
catabolic hormone cortisol and the anabolic hormone testosterone compared with the …

A retrospective case-matched analysis was performed comparing 189 myeloma patients
treated with allogeneic bone marrow transplantation (allo-BMT) with an equal number of …

The role of ursodeoxycholic acid (UDCA) in the prevention of hepatic complications after
allogeneic stem cell transplantation was studied in a prospective randomized open-label …

Biologic and clinical observations suggest that combining imatinib with IFN-α may improve
treatment outcome in chronic myeloid leukemia (CML). We randomized newly diagnosed …

The Nordic Myeloma Study Group conducted an open randomized trial to compare
bortezomib as consolidation therapy given after high-dose therapy and autologous stem cell …

Purpose Patients with Richter's syndrome (RS) have a poor prognosis with conventional
chemotherapy. The aim of this study was to evaluate the outcome after autologous stem-cell …

Inhibitors of B-cell lymphoma-2 (BCL-2) such as venetoclax (ABT-199) and navitoclax (ABT-263)
are clinically explored in several cancer types, including acute myeloid leukemia (AML)…

Improvement of graft-versus-host disease prophylaxis remains an important goal in
allogeneic hematopoietic stem cell transplantation. Based on reports of possibly preferential …

We randomised 46 newly diagnosed patients with chronic myeloid leukaemia (median age
56) to receive dasatinib 100 mg QD or imatinib 400 mg QD and report outcome as an …

We report the long-term results of a prospective randomized study on the use of
ursodeoxycholic acid (UDCA) for prevention of hepatic complications after allogeneic stem cell …